Nykredit A/S’s NeoGenomics NEO Stock Holding History

Nykredit A/S’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.8K	Buy	+1,904	New	+$18.4K	﹤0.01%	1637

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Nykredit A/S's NEO Position: Q2 2026 in Review

Nykredit A/S opened a new position in NeoGenomics (NEO) in Q2 2026: 1,904 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #1637 among its holdings.

197 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Nykredit A/S held 1,904 shares of NeoGenomics worth $27.8K as of Q2 2026.
NeoGenomics was a new Nykredit A/S position in Q2 2026.
NeoGenomics made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1637 holding.
197 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.